178 related articles for article (PubMed ID: 22664499)
41. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
[TBL] [Abstract][Full Text] [Related]
42. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
Front Immunol; 2019; 10():1153. PubMed ID: 31191532
[TBL] [Abstract][Full Text] [Related]
43. Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.
Yang X; Lin K; Ni S; Wang J; Tian Q; Chen H; Brown MA; Zheng K; Zhai W; Sun L; Jin S; Wang J
Arthritis Res Ther; 2017 Nov; 19(1):257. PubMed ID: 29166915
[TBL] [Abstract][Full Text] [Related]
44. Serologic Markers Are Associated With Ocular Staining Score in Primary Sjögren Syndrome.
Lim SA; Nam S; Kwok SK; Park SH; Chung SH
Cornea; 2015 Nov; 34(11):1466-70. PubMed ID: 26356755
[TBL] [Abstract][Full Text] [Related]
45. Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.
Li Y; Sun X; Zhang X; Yang Y; Jia R; Liu X; Li R; Liu Y; Li Z
Clin Rheumatol; 2014 Dec; 33(12):1745-50. PubMed ID: 25178777
[TBL] [Abstract][Full Text] [Related]
46. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
47. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
Jin YJ; Sun L; Yang L; Xing R; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
[TBL] [Abstract][Full Text] [Related]
48. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
[TBL] [Abstract][Full Text] [Related]
49. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
50. Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sjögren's syndrome secondary to rheumatoid arthritis.
Mieliauskaite D; Venalis P; Dumalakiene I; Venalis A; Distler J
Autoimmunity; 2009 May; 42(4):356-8. PubMed ID: 19811300
[TBL] [Abstract][Full Text] [Related]
51. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
He J; Fang W; Li ZG
Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):366-8. PubMed ID: 18953942
[TBL] [Abstract][Full Text] [Related]
52. Serum level of IL-6 in patients with primary and secondary Sjögren's syndrome.
Slezák R; Krejsek J; Kopecký O; Jelenová H
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(2):59-60. PubMed ID: 8584859
[TBL] [Abstract][Full Text] [Related]
53. A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.
Benchabane S; Boudjelida A; Toumi R; Belguendouz H; Youinou P; Touil-Boukoffa C
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):386-97. PubMed ID: 27207443
[TBL] [Abstract][Full Text] [Related]
54. Interferon-β inhibits inflammatory responses mediators via suppression of iNOS signaling pathway in PBMCs from patients with primary Sjögren's syndrome.
Benchabane S; Belkhelfa M; Belguendouz H; Zidi S; Boudjelida A; Youinou P; Touil-Boukoffa C
Inflammopharmacology; 2018 Oct; 26(5):1165-1174. PubMed ID: 29869303
[TBL] [Abstract][Full Text] [Related]
55. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
56. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
[TBL] [Abstract][Full Text] [Related]
57. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
58. IL-17A and IL-17F polymorphisms in rheumatoid arthritis and Sjögren's syndrome.
Carvalho CN; do Carmo RF; Duarte AL; Carvalho AA; Leão JC; Gueiros LA
Clin Oral Investig; 2016 Apr; 20(3):495-502. PubMed ID: 26232893
[TBL] [Abstract][Full Text] [Related]
59. Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.
Katsikis PD; Youinou PY; Galanopoulou V; Papadopoulos NM; Tzioufas AG; Moutsopoulos HM
Clin Exp Immunol; 1990 Dec; 82(3):509-14. PubMed ID: 2124958
[TBL] [Abstract][Full Text] [Related]
60. Cigarette smoking in primary Sjögren's syndrome: positive association only with ANA positivity.
Karabulut G; Kitapcioglu G; Inal V; Kalfa M; Yargucu F; Keser G; Emmungil H; Gokmen NM; Kocanaogullari H; Aksu K
Mod Rheumatol; 2011 Dec; 21(6):602-7. PubMed ID: 21445716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
